Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ottaviani

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Cancer Genetics|August 27, 2019
Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changesD Tolomeo, A L'Abbate, A Lonoce, et al.
Haematologica|September 12, 2000
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantationG Martinelli, C Terragna, E Zamagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myelomaG Martinelli, C Terragna, E Zamagni, et al.
Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.
Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.
Haematologica|March 20, 2001
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemiaM Amabile, B Giannini, N Testoni, et al.
British Journal of Haematology|May 25, 2023
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failureC Sartor, L Brunetti, E Audisio, et al.
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Leukemia|May 18, 2007
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.
The Pharmacogenomics Journal|May 16, 2012
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and IdarubicinI Iacobucci, A Lonetti, A Candoni, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Cancer Genetics|August 27, 2019
Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changesD Tolomeo, A L'Abbate, A Lonoce, et al.
Haematologica|September 12, 2000
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantationG Martinelli, C Terragna, E Zamagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myelomaG Martinelli, C Terragna, E Zamagni, et al.
Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.
Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.
Haematologica|March 20, 2001
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemiaM Amabile, B Giannini, N Testoni, et al.
British Journal of Haematology|May 25, 2023
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failureC Sartor, L Brunetti, E Audisio, et al.
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Leukemia|May 18, 2007
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.
The Pharmacogenomics Journal|May 16, 2012
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and IdarubicinI Iacobucci, A Lonetti, A Candoni, et al.
Pageof 18